Evofem Biosciences (EVFM) Gross Margin (2020 - 2026)
Evofem Biosciences' Gross Margin was 80.59% in Q2 2026, down 3.76 percentage points from 84.35% a year earlier but up 26.20 percentage points from the prior quarter.
Powered by 
Analysis
Evofem Biosciences (EVFM) Gross Margin (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Evofem Biosciences' Gross Margin was 75.52% through Jun 30, 2026, down 4.21 percentage points year-over-year; for FY2025, it was 77.12%, down 3.08 percentage points from FY2024.
- Gross Margin shows a five-year change of +82.06 percentage points (FY2020 to FY2025).
- In earlier years, Gross Margin was 80.20% in FY2024 (+15.94 pp), 64.26% in FY2023 (-9.52 pp), 73.78% in FY2022 (+22.97 pp) and 50.81% in FY2021 (+55.75 pp).
- Quarterly Gross Margin has moved between -112.15% (Q4 2022) and 84.35% (Q2 2025) over five years.
- Compared with a year earlier, Gross Margin has declined for three straight quarters, with an average year-over-year change of -2.03 percentage points over the last eight quarters.
- The best year-over-year quarter for Gross Margin over five years was Q4 2023 (a gain of 192.44 percentage points); the worst was Q4 2022 (a drop of 163.00 percentage points).
- Per Business Quant data, EVFM's Gross Margin in the three quarters before Q2 2026 was 54.39% (Q1 2026), 72.89% (Q4 2025) and 81.72% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 85.78% |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 74.74% |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 73.54% |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 72.04% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 79.76% |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 72.78% |
| 10 | Evofem Biosciences | 878,961.72 | 878,961.72 | 2.12 Mn | 80.59% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 80.59% |
| Mar 31, 2026 | 54.39% |
| Dec 31, 2025 | 72.89% |
| Sep 30, 2025 | 81.72% |
| Jun 30, 2025 | 84.35% |
| Mar 31, 2025 | 56.80% |
| Dec 31, 2024 | 78.72% |
| Sep 30, 2024 | 80.67% |
| Jun 30, 2024 | 81.51% |
| Mar 31, 2024 | 81.02% |
| Dec 31, 2023 | 80.29% |
| Sep 30, 2023 | 63.05% |
| Jun 30, 2023 | 6.71% |
| Mar 31, 2023 | 76.31% |
| Dec 31, 2022 | -112.15% |
| Sep 30, 2022 | 73.63% |
| Jun 30, 2022 | 78.70% |
| Mar 31, 2022 | 74.92% |
| Dec 31, 2021 | 50.84% |
| Sep 30, 2021 | 44.22% |
API Access
Evofem Biosciences Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=EVFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "EVFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=EVFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();